Completed PHASE1 INTERVENTIONAL 2-arm NCT02708173

Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older

Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention

Conditions Quadrivalent Influenza Virus Vaccine

Interventions One dose of Quadrivalent Influenza Virus Vaccine

Updated 6 times since 2017 Last updated: Aug 12, 2016 Started: Mar 31, 2016 Primary completion: Mar 31, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Quadrivalent Influenza Virus Vaccine, this trial is completed. The trial is conducted by Beijing Chaoyang District Centre for Disease Control and Prevention and has accumulated 6 data snapshots since 2016. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Chaoyang District Centre for Disease Control and Prevention

Data source: Beijing Chaoyang District Centre for Disease Control and Prevention

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China